This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Yunju Oh: Innovator in Heterocyclic Compounds
Introduction
Yunju Oh is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on heterocyclic compounds. His research focuses on developing solutions for diseases linked to prolyl-tRNA synthetase activity.
Latest Patents
Yunju Oh holds 1 patent for his invention titled "Heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same." This patent describes a heterocyclic compound represented by Chemical Formula 1, which can be utilized for the prevention or treatment of diseases caused by abnormalities in PRS activity. The invention also includes a method for preparing the compound and a pharmaceutical composition that incorporates it.
Career Highlights
Yunju Oh is currently employed at Daewoong Pharmaceutical Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His work has the potential to impact the treatment of various diseases, showcasing his commitment to improving healthcare through scientific discovery.
Collaborations
Yunju Oh collaborates with esteemed colleagues such as Bong-Yong Lee and Min-Jae Cho. Their combined expertise enhances the research and development efforts at Daewoong Pharmaceutical Co., Ltd.
Conclusion
Yunju Oh's contributions to the field of pharmaceuticals, particularly through his patent on heterocyclic compounds, highlight his role as an innovator. His work not only advances scientific knowledge but also holds promise for future medical applications.